Search - tctmd.com

Displaying 881 - 900 of 1818

Sort: Relevancy | Date

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake

News Daily News

Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake

August 10, 2018

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

August 09, 2018

Women With Acute MI More Likely to Survive If Treated by Female Physicians

News Daily News

Women With Acute MI More Likely to Survive If Treated by Female Physicians

August 08, 2018

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

August 01, 2018

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

Acute MI Rates on the Rise Among Pregnant Women in the US

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

July 24, 2018

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

Discharge Against Medical Advice After PCI Rare but Deadly

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

July 03, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

CVD Prevention and Control Remains a Challenge in India

News Daily News

CVD Prevention and Control Remains a Challenge in India

June 26, 2018

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

June 25, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

News Daily News

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

June 06, 2018

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

News Daily News

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

June 06, 2018

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

News Daily News

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

June 04, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.